Peculiarities of cardiovascular remodeling in hypertensive patients at high additional risk with concomitant subclinical hypothyroidism
DOI:
https://doi.org/10.14739/2310-1210.2019.1.155792Keywords:
hypothyroidism, hypertension, ventricular remodeling, vascular remodelingAbstract
Arterial hypertension affects over 12 million people in Ukraine, which accounts for about 30 % of the adult population, and is a powerful independent risk factor for cardiovascular morbidity and mortality.
Subclinical hypothyroidism (SH) is also an independent causative factor of the cardiovascular risk and is associated with the development of ischemic heart disease, myocardial infarction, chronic heart failure and increased mortality from cardiovascular diseases regardless of sex, age or pre-existing cardiac pathology. Therefore, there is a need to study the influence of subclinical hypothyroidism on the cardiovascular remodeling peculiarities in patients with arterial hypertension (AH).
Material and methods. The study involved 124 patients with AH stage II divided into two groups. The group of patients with AH without SH included 92 patients (women 81.52 % (75), men 18.48 % (17)) and 32 patients (women 87.5 % (28), men 12.5 % (4)) represented the group with AH and concomitant SH. The groups of patients were comparable in age (P = 0.093), sex (P = 0.44319), height (P = 0.993), weight (P = 0.719), body surface area (P = 0.901), body mass index (P = 0.669). In all patients underwent arterial blood pressure measurement (OMRON 750 IT,Japan), echocardiography and ultrasound of carotid arteries using the original QIMT software on My Lab 50 (Esaote,Italy).
Results. In patients with AH with the concomitant SH, in contrast to patients with AH without SH, a significant increase in indexes of the intima-media complex thickness of the right common carotid artery by 8.2% (P < 0.05) and the left common carotid artery by 7.9 % (P < 0.05) was observed.
Changes of structural, geometrical and functional indexes of the heart in patients with AH and SH were significant increase in the left atrial size by 3.5 % (P < 0.05), end diastolic size by 3.0 % (P < 0.05) and end systolic size of the left ventricle by 2.3 % (P < 0.05), myocardial mass index by 11.1 % (P < 0.05), index Е/Е´ by 13.0 % (P < 0.05), gradient of transpulmonary flow by 6.6 % (P < 0.05) in comparison to patients with AH without SH.
Conclusions. In patients with AH and concomitant SH in contrast to patients with AH without SH, an increase in thickness of the intima-media complex of both common carotid arteries with comparable diameters of vessels has been established, as well as increase in size of the left atrium, left ventricular myocardial mass index mainly due to the left ventricular dilation, Е/Е´ index and pressure gradient in the pulmonary artery suggesting an increase in the end diastolic pressure and the left ventricular diastolic dysfunction.
References
Robocha hrupa z arterialnoi hipertenzii Ukrainskoi asotsiatsii kardiolohiv. (2012). Arterialna hipertenziia. Onovlena ta adaptovana klinichna nastanova, zasnovana na dokazakh (2012 rik): praktychni rekomendatsii [Arterial hypertension. Updated and adapted clinical guidance, based on the evidence of 2012: Practical recommendations]. Arterial'naya gipertenziya, 1, 96–152. [in Ukranian].
Vernigorodsky, V. S., Fetisova, N. M., & Vernigorodskaya, M. V. (2013). Provospalitel'nye citokiny i ikh rol' v razvitii serdechno-sosudistykh oslozhnenij u bol'nykh gipotireozom [Proinflammatory cytokines and their role in the development of cardiovascular complications in patients with hypothyroidism]. Rossijskij mediko-biologicheskij vestnik im. akademika I.P. Pavlova, 2, 93–96. [in Russian].
Nekrasova, T. A., Ledentsova, O. V., Strongin, L. G., Kazakova, L. V., & Lukushkina, A. Iu. (2011). Osobennosti gemodinamiki u bol'nykh s autoimmunnym tireoiditom i subklinicheskim gipotireozom v raznykh vozrastnykh gruppakh [Specific features of hemodynamics in the patients of different age groups presenting with autoimmune thyroiditis and subclinical hypothyroidism]. Problemy e'ndokrinologii, 57(3), 21–24. [in Russian].
Petunina, N. A., & Trukhina, L. V. (2013). Gipotireoz [Hypertireoidism]. Rossijskij medicinskij zhurnal, 21(12), 664–666. [in Russian].
Kononenko, A. H., & Kravchenko, V. H. (2016). Zminy pokaznykiv obminu rechovyn pry eksperymentalnomu hipotyreozi [Changes in metabolic rate in experimental hypothyroidism]. Mizhnarodnyi endokrynolohichnyi zhurnal, 2(74), 174. [in Ukrainian].
Kadzharyan, V. G., Melnik, A. I., Bidzilya, P. P., & Solovyuk, S. A. (2014). Otsinka stanu lipidnoho obminu pid chas dysfunktsii shchytovydnoi zalozy [Assessment of the state of lipid exchange in thyroid dysfunction]. Zaporozhye medical journal, 1(82), 20–22. [in Ukrainian]. doi: https://doi.org/10.14739/2310-1210.2014.1.23657
Horodynska, O. Yu., & Bobyriova, L. Ye. (2016). Prohnostychna kharakterystyka poshyrennia hipotyreozu v Poltavskii oblasti ta v Ukraini v tsilomu za umov yodnoho defitsytu [Prognostic characteristics of hypothyroidism prevalence in the Poltava region and in Ukraine under conditions of iodine deficiency]. Mizhnarodnyi endokrynolohichnyi zhurnal, 2(74), 44–49. [in Ukrainian].
Cappola, А. R., & Ladenson, P. W. (2003). Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Met., 88(6), 2438–2444. doi: 10.1210/jc.2003-030398
Monzani, F., Caraccio, N., Kozàkowà, M., Dardano, A., Vittone, F., Virdis, A., et al. (2004). Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study. The Journal Of Clinical Endocrinology & Metabolism, 89(5), 2099–2106. doi: 10.1210/jc.2003-031669
Biondi, B., & Klein, I. (2004). Hypothyroidism as a risk factor for cardiovascular disease. Endocrine, 24(1), 1–13. doi: 10.1385/endo:24:1:001
Hak, A., Pols, H., Visser, T., Drexhage, H., Hofman, A., & Witteman, J. (2000). Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Annals Of Internal Medicine, 132(4), 270. doi: 10.7326/0003-4819-132-4-200002150-00004.
Lioudaki, E., Mavroeidi, N., Mikhailidis, D., & Ganotakis, E. (2013). Subclinical hypothyroidism and vascular risk: Αn update. Hormones, 12(4), 495–506. doi: 10.14310/horm.2002.1437
Rodondi, N., den Elzen, W. P., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., et al. (2010). Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality. JAMA, 304(12), 1365–74. doi: 10.1001/jama.2010.1361
Walsh, J., Bremner, A., Bulsara, M., O’Leary, P., Leedman, P., Feddema, P., & Michelangeli, V. (2005). Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives Of Internal Medicine, 165(21), 2467–72. doi: 10.1001/archinte.165.21.2467
Karmisholt, J., Andersen, S., & Laurberg, P. (2010). Analytical goals for thyroid function tests when monitoring patients with untreated subclinical hypothyroidism. Scandinavian Journal Of Clinical And Laboratory Investigation, 70(4), 264–268. doi: 10.3109/00365511003782778
Andersen, M. N., Olsen, A. S., Madsen, J. C., Kristensen, S. L., Faber, J., Torp-Pedersen, C., et al. (2016). Long-term outcome in levothyroxine treated patients with subclinical hypothyroidism and concomitant heart disease. The Journal Of Clinical Endocrinology & Metabolism, 101(11), 170–177. doi: 10.1210/jc.2016-2226
Biondi, B. (2012). Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Practice & Research Clinical Endocrinology & Metabolism, 26(4), 431–446. doi: 10.1016/j.beem.2011.12.004
Danzi, S., & Klein, I. (2014). Thyroid Disease and the Cardiovascular System. Endocrinology And Metabolism Clinics Of North America, 43(2), 517–528. doi: 10.1016/j.ecl.2014.02.005
Faber, J., & Selmer, C. (2014). Cardiovascular Issues in Endocrinology. Front Horm Res.Basel. Karger., 43, 45–56. doi: 10.1159/000360558
Cabral, M., Teixeira, P., Silva, N., Morais, F., Soares, D., Salles, E. et al. (2009). Normal flow-mediated vasodilatation of the brachial artery and carotid artery intima-media thickness in subclinical hypothyroidism. Braz. J. Med. Biol. Res., 42(5), 426–432. doi: 10.1590/S0100-879X2009000500005
Chiche, F., Jublanc, C., Coudert, M., Carreau, V., Kahn, J., & Bruckert, E. (2009). Hypothyroidism is not associated with increased carotid atherosclerosis when cardiovascular risk factors are accounted for in hyperlipidemic patients. Atherosclerosis, 203(1), 269–276. doi: 10.1016/j.atherosclerosis.2008.06.011
Takashima, N., Niwa, Y., Mannami, T., Tomoike, H., & Iwai, N. (2007). Characterization of subclinical thyroid dysfunction from cardiovascular and metabolic viewpoints. Circulation Journal, 71(2), 191–195. doi: 10.1253/circj.71.191
Vierhapper, H., Nardi, A., Grösser, P., Raber, W., & Gessl, A. (2000). Low-density lipoprotein cholesterol in subclinical hypothyroidism. Thyroid, 10(11), 981–984. doi: 10.1089/thy.2000.10.981
Altshuler, N. E., Petunina, N. A., Nikolayev, A. P., & Chernyshova, T. V. (2011). Sravnitel'nyj analiz koncentracii gormonov zhirovoj tkani, pokazatelej lipidnogo obmena i insulinorezistentnosti pri subklinicheskom gipotireoze v zavisimosti ot nalichiya/otsutstviya zamestitel'noj terapii levotiroksinom [A comparative analysis of the lipid tissue hormones concentration, lipid metabolism and insulin resistance in subclinical hypothyroidism depending on the presence/absence of the levothyroxin replacement therapy]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 7(3), 53–58. [in Russian].
Nekrasova, T. A., Shcherbatyuk, T. G., Davydenko, D. V., Ledentsova, O. V., & Strongin, L. G. (2011). Osobennosti perekisnogo okisleniya lipidov i belkov pri autoimmunnom tireoidite bez i s minimal'noj tireoidnoj disfunkciej [Peculiarities of lipid and protein peroxidation in autoimmune thyroiditis with and without mild thyroid dysfunction]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 7(4), 38–43. doi: 10.14341/ket20117438-43
Allport, J., McCahon, D., Hobbs, F., & Roberts, L. (2012). Why are GPs treating subclinical hypothyroidism? Case note review and GP survey. Primary Health Care Research & Development, 14(2), 175–184. doi: 10.1017/s1463423612000230
Brenta, G., Vaisman, M., Sgarbi, J. A., Bergoglio, L. M., Andrada, N. C., Bravo, P. P., et al. (2013). Clinical practice guidelines for the management of hypothyroidism. Arq Bras Endocrinol Metabol., 57(4), 265–291. http://dx.doi.org/10.1590/S0004-27302013000400003
Cooper, D., & Biondi, B. (2012). Subclinical thyroid disease. The Lancet, 379(9821), 1142–1154. doi: 10.1016/s0140-6736(11)60276-6
Duntas, L., & Wartofsky, L. (2007). Cardiovascular Risk and Subclinical Hypothyroidism: Focus on Lipids and New Emerging Risk Factors. What Is the Evidence? Thyroid, 17(11), 1075–1084. doi: 10.1089/thy.2007.0116
Sviridonova, M. А., Fadeyev, V. V., Sych, Y. P., & Melnichenko, G. A. (2013). Clinical significance of TSH circadian variability in patients with hypothyroidism. Endocr Res, 38(1), 24–31. doi: 10.3109/07435800.2012.710696.
Virgini, V., Collet, T. H., Christ, E., Aujesky, D., & Rodondi, N. (2012). Should we screen and treat subclinical hypothyroidism? Rev Med Suisse, 8(331), 501–506.
Weiss, I., Bloomgarden, N., & Frishman, W. (2011). Subclinical Hypothyroidism and Cardiovascular Risk. Cardiology In Review, 19(6), 291–299. doi: 10.1097/crd.0b013e318227df87
Pertseva, N. O., & Еiner, K. M. (2017). Osoblyvosti vplyvu subklinichnoho hipotyreozu na sertsevo-sudynnu systemu [Features of the influence of subclinical hypothyroidism on the cardiovascular system]. Medychni perspektyvy, 22(4), 49–55. doi: 10.26641/2307-0404.2017.4.117667 [in Ukrainian].
Marwick, T., Gillebert, T., Aurigemma, G., Chirinos, J., Derumeaux, G., Galderisi, M., et al. (2015). Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging, 16(6), 577–605. doi: 10.1093/ehjci/jev076
Kravez, E. B., Idrisova, E. M., Damdindorsh, D., & Latypova, V. N. (2009). E'khokardiograficheskie osobennosti u pacientov s gipotireozom razlichnoj vyrazhennosti v iskhode autoimmunnogo tireoidita [Echocardiographycal Features in Patients with Hypothyroidism of Different Sevirity due to Hashimoto’s Thyroiditis]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 5(2), 45–50. [in Russian].
Fadeyev, V. V. (2012). Po materialam klinicheskikh rekomendacij Amerikanskoj associacii klinicheskikh e'ndokrinologov i Amerikanskoj tireoidnoj associacii po diagnostike i lecheniyu gipotireoza u vzroslyh [Clinical Practice Guidelines for Hypothyroidism in Adults: Co sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 8(3), 9–16. [in Russian].
Fadeyev, V. V., & Mel'nichenko, G. A. (2004).Gipotireoz. Rukovodstvo dlya vrachej [Hyperthyroidism. Guide for doctors]. Moscow. [in Russian].
Nekrasova, T. A., Strongin, L. G., Ledentsova, O. V., & Kasakova, L. V. (2012). Osobennosti diastolicheskoj funkcii serdca pri autoimmunnom tireoidite s raznoj stepen'yu minimal'noj tireoidnoj nedostatochnosti [Peculiarities of myocardial diastolic function in patients with autoimmune thyroiditis divided according to the mild hypothyroidism range]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 8(4), 42–46. [in Russian].
Nagasaki, Т., Inaba, M., Henmi Y., Kumeda, Y., Ueda, M., Tahara, H., et al. (2003). Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin Endocrinol, 59(5), 607–612. doi: 10.1046/j.1365-2265.2003.01893.x.
Papaioannou, G., Lagasse, M., Mather, J., & Thompson, P. (2004). Treating hypothyroidism improves endothelial function. Metabolism, 53(3), 278–279. doi: 10.1016/j.metabol.2003.10.003
Cikim, A., Oflaz, H., Ozbey, N., Cikim, K., Umman, S., Meric, M., et al. (2004). Evaluation of Endothelial Function in Subclinical Hypothyroidism and Subclinical Hyperthyroidism. Thyroid, 14(8), 605–609. doi: 10.1089/1050725041692891
Völzke, H., Robinson, D., Schminke, U., Lüdemann, J., Rettig, R., Felix, S., et al. (2004). Thyroid Function and Carotid Wall Thickness. J Clin Endocrinol Metab., 89(5), 2145–2149. doi: 10.1210/jc.2003-031028
Erbil, Y., Özbey, N., Giriş, M., Salmaslıoğlu, A., Özarmağan, S., & Tezelman, S. (2007). Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy. British Journal of Surgery, 94(12), 1485–1490. doi: 10.1002/bjs.5915
Taddei, S., Caraccio, N., Virdis, A., Dardano, A., Versari, D., & Ghiadoni, L. (2003). Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. The Journal of Clinical Endocrinology & Metabolism, 88(8), 3731–3737. doi: 10.1210/jc.2003-030039
Razvi, S., Ingoe, L., Keeka, G., Oates, C., McMillan, C., & Weaver, J. (2007). The beneficial effect ofl-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. The Journal of Clinical Endocrinology & Metabolism, 92(5), 1715–1723. doi: 10.1210/jc.2006-1869
(2002). National Cholesterol Education Program (USA). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult treatment panel III) : final report / National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Washington.
Corretti, M., Anderson, T., Benjamin, E., Celermajer, D., Charbonneau, F., Creager, M., et al. (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. Journal of The American College of Cardiology, 39(2), 257–265. doi: 10.1016/s0735-1097(01)01746-6
Klein, I., & Ojamaa, K. (2001). Thyroid hormone and the cardiovascular system. New England Journal of Medicine, 344(7), 501–509. doi: 10.1056/nejm200102153440707
Faber, J., Petersen, L., Wiinberg, N., Schifter, S., & Mehlsen, J. (2002). Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid, 12(4), 319–324. doi: 10.1089/10507250252949450
Bauwens, F., Duprez, D., De Buyzere, M., De Backer, T., Kaufman, J., Van Hoecke, J., et al. (1991). Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension. The American Journal of Cardiology, 68(9), 925–929. doi: 10.1016/0002-9149(91)90410-m
Abramova, N. O., & Pashkovska, N. V. (2017). Osobennosti obmena tireoidnykh gormonov v zavisimosti ot S/T polimorfizma gena DIO 1 i PRO197leu polimorfizma gena GPX1 u bol'nykh s metabolicheskim sindromom [Peculiarities of thyroid hormones metabolism depending on the c/t polymorphism in the dio 1 gene and pro197leu polymorphism in the gpx1 gene in patients with metabolic syndrome]. Vrachebnoe delo, 3–4, 37–42. [in Russian].
Myasoyedova, S. Ye. (2014). Serdechno-sosudistye narusheniya pri gipotireoze i adipokiny [Cardiovascular disorders with hypothyroidism and adipokines]. Klinicist, 2, 4–6. [in Russian].
Zdor, V. V. (2017). Vzaimosvyaz' gormonal'noj i citokinovoj regulyacii pri autoimunnom tireoidite [Correlation of hormonal and cytokines regulation in case of autoimmune thyroiditis]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 2, 45–56. [in Russian].
Rymar, O. D., Maksimov, V. N., Malyshenko, Y. A., Tatarnikova, N. P., Shachtshneider, E. V., Shcherbakova, L. V., & Mustafina, S. V. (2015). Klinicheskie i molekulyarno-geneticheskie aspekty lipidnogo profilya u zhenschin s autoimmunnym tireoiditom [Clinical and genetics aspects of the lipid profile in women with autoimmune thyroiditis]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 11(4), 21–30. [in Russian]. doi: 10.14341/ket2015421-30
Samitin, V., & Rodionova, T. (2009). Faktory serdechno-sosudistogo riska, svyazannye s funkciej e'ndoteliya, pri subklinicheskom gipotireoze [Endothelium-related Cardiovascular Risk Factors in Subclinical Hypothyroidism]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 5(1), 26–29. [in Russian].
Sviridonova, M. A., Ilyin, A. V., Kolesnikova, G. S., & Fadeyev, V. V. (2009). Vozmozhnye posledstviya snizheniya referensnogo intervala dlya urovnya TTG [Possible Consequences of Changing of the TSH Reference Ranges]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 2, 30–33. [in Russian].
Podzolkov, A. V., & Fadeyev, V. V. (2010). Vysoko- i nizko-normal'nyj uroven' TTG: klinicheskaya kartina, psikhoe'mocional'naya sfera i kachestvo zhizni pacientov s gipotireozom [The TSH dynamics in upper and low normal range in patients with primary hypothyroidism: clinical presentation, well being and quality of life]. Klinicheskaya i e'ksperimental'naya tireoidologiya, 6(4), 58–68. [in Russian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
